Betaine (Trimethylglycine)

Betaine, or trimethylglycine (TMG), is a methyl donor derived from choline oxidation that supports the remethylation of homocysteine to methionine via the enzyme betaine-homocysteine methyltransferase (BHMT). It plays a central role in one-carbon metabolism and has been studied for cardiovascular, liver, and athletic performance applications.

Category: Compound Evidence: 4/10 Tier: Emerging
Betaine (Trimethylglycine) — Hermetica Encyclopedia

Origin & History

Betaine (trimethylglycine) is a modified amino acid derived from glycine with three methyl groups, naturally occurring in plants like beets, spinach, and whole grains, as well as seafood. It is biosynthesized in organisms via oxidation of choline and commercially extracted from sugar beets (Beta vulgaris) or produced synthetically.

Historical & Cultural Context

No historical or traditional medicine uses are mentioned in the available sources. The research does not include information about traditional systems or historical applications.

Health Benefits

• May support methylation processes as a methyl donor (mechanism identified, no clinical evidence provided) • Potential anti-inflammatory effects (mentioned but no clinical trials cited) • May work with folate and B12 in metabolic pathways (biochemical role described, no human studies) • Could maintain DNA methylation patterns (theoretical based on mechanism) • May protect certain enzymes from salt inhibition (observed in cyanobacteria, not humans)

How It Works

Betaine acts as an osmolyte and methyl donor, transferring one methyl group to homocysteine via betaine-homocysteine methyltransferase (BHMT), converting it to methionine and dimethylglycine (DMG). This regenerates S-adenosylmethionine (SAM), the universal methyl donor required for over 200 methylation reactions including DNA methylation, neurotransmitter synthesis, and phosphatidylcholine production. Independently of BHMT, betaine stabilizes intracellular protein structures under osmotic stress by accumulating in cells as a compatible solute, protecting renal and hepatic tissue.

Scientific Research

The research dossier contains no specific human clinical trials, RCTs, or meta-analyses with PMIDs. No studies with sample sizes, designs, or clinical outcomes are described in the available sources.

Clinical Summary

Randomized controlled trials using 2.5–6 g/day of betaine supplementation have demonstrated reductions in fasting plasma homocysteine of approximately 10–20% in healthy adults, though effect sizes vary by MTHFR genotype and baseline folate status. A double-blind crossover study (n=46) published in the Journal of Nutrition found 6 g/day reduced homocysteine by 20% over six weeks. In athletic performance, several RCTs with sample sizes of 12–30 trained individuals report modest improvements in power output (2–5%) and repetition volume during resistance exercise at doses of 2.5 g/day, though not all studies replicate these findings. Evidence for non-alcoholic fatty liver disease (NAFLD) improvement exists from small open-label trials but lacks large-scale RCT confirmation.

Nutritional Profile

Betaine (Trimethylglycine) is a small zwitterionic compound (molecular weight 117.15 g/mol) derived from the amino acid glycine with three methyl groups attached to the nitrogen atom. It is not a traditional macronutrient but functions as a specialized bioactive compound and osmolyte. As a pure compound, it contains no fat, fiber, or significant caloric density in supplemental doses. Typical supplemental doses range from 500mg to 3000mg per day. Naturally occurring dietary concentrations: wheat germ (~1339 mg/100g dry weight), wheat bran (~1339 mg/100g), spinach (~600-645 mg/100g fresh weight), beets (~114-297 mg/100g fresh weight), quinoa (~390 mg/100g dry weight), and shellfish such as shrimp (~218 mg/100g). As a methyl donor, it carries three labile methyl groups available for transmethylation reactions, donating one methyl group to homocysteine via betaine-homocysteine methyltransferase (BHMT) to form dimethylglycine and methionine. Bioavailability of supplemental betaine HCl and anhydrous betaine is estimated at approximately 70-95% via intestinal absorption through sodium-coupled neutral amino acid transporters (SNAT2) and organic cation transporters. It is water-soluble, distributed primarily to liver, kidney, and brain tissues where osmotic regulation is critical. No significant vitamin, mineral, or fiber content is inherent to the compound itself in isolated form.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are provided in the research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Choline, Folic Acid, Vitamin B12, S-adenosylmethionine (SAMe)

Safety & Interactions

Betaine is generally well tolerated at doses up to 6 g/day; the most commonly reported side effect is a fishy body odor due to conversion to trimethylamine (TMA) by gut bacteria, particularly at higher doses. Gastrointestinal discomfort including nausea and diarrhea has been reported at doses exceeding 4 g/day. Betaine may increase LDL cholesterol in some individuals, particularly at doses of 6 g/day, and should be used cautiously in those with dyslipidemia or cardiovascular risk. It should not replace medical folate or B12 therapy for hyperhomocysteinemia, and safety data in pregnancy and lactation are insufficient to make a recommendation.